Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 65/100

Failure Rate

16.7%

1 terminated/withdrawn out of 6 trials

Success Rate

83.3%

-3.2% vs industry average

Late-Stage Pipeline

17%

1 trials in Phase 3/4

Results Transparency

40%

2 of 5 completed trials have results

Key Signals

2 with results

Enrollment Performance

Analytics

N/A

2(40.0%)

Phase 2

1(20.0%)

Phase 3

1(20.0%)

Phase 1

1(20.0%)

5Total

N/A(2)

Phase 2(1)

Phase 3(1)

Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials

NCT03254186Phase 2Withdrawn

Safety and Efficacy of Propranolol in the Treatment of Tardive Dyskinesia

Role: collaborator

NCT01380197Phase 3Completed

Choosing Opioid Management for Pain and Analyzing Acute Chest Syndrome (ACS) Rates Equally

Role: collaborator

NCT01659762Phase 1Completed

A Phase I Study Evaluating Autologous Bone Marrow Derived Mesenchymal Stromal for Crohn's Disease.

Role: collaborator

NCT00892554Not ApplicableCompleted

The Effect of Supplemental Docosahexaenoic Acid (DHA) on Neurocognitive Outcomes in Teen and Adult Women With Phenylketonuria(PKU)

Role: collaborator

NCT00688844Completed

Nutritional and Neurotransmitter Changes in PKU Subjects on BH4

Role: collaborator

NCT01606085Not ApplicableCompleted

Cost Effectiveness and Quality of Life in Heart Failure Patients With Diabetes

Role: collaborator

All 6 trials loaded